Overview
Liquid biopsy leader using AI for cancer detection and monitoring.
Details
Guardant360 (advanced cancer), Guardant Reveal (MRD), and Shield (CRC screening) combine ctDNA sequencing with ML. Public on Nasdaq (GH).
Tags
liquid-biopsy, oncology, ctdna, mrd, screening, public-company